From: Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
Group | FEV1 (L) | FVC (L) | FEV1/FVC (%) | |||
---|---|---|---|---|---|---|
 | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment |
The control group (n = 78) | 1.26 ± 0.30 | 1.52 ± 0.33* | 2.64 ± 0.58 | 3.02 ± 0.79* | 48.56 ± 4.58 | 50.36 ± 4.98* |
The observation group (n = 80) | 1.27 ± 0.29 | 1.81 ± 0.38* | 2.59 ± 0.62 | 3.42 ± 0.80* | 49.02 ± 4.29 | 58.56 ± 5.25* |
t value | 0.213 | 5.117 | 0.523 | 3.162 | 0.652 | 10.068 |
P value | 0.832 |  < 0.001 | 0.602 | 0.002 | 0.516 |  < 0.001 |